Client Challenge

Discover how professionals are approaching metabolic diseases, treatment gaps, and patient care strategies in this detailed survey analysis.

Access the full report:
www.slideshare.net/slideshow/he...

#HealthcareAnalytics #MetabolicDiseases #HealthTech #PharmaTrends #MedicalInsights #Healthcare

HCP Perspectives on Metabolic Diseases | US & EU Survey Insights from 50 HCPs across US & EU on metabolic diseases, treatment challenges, GLP-1 adoption, and patient outcomes in diabetes and obesity care.

Metabolic diseases are rising rapidly across the US and Europe, with over 90% of healthcare professionals reporting high prevalence.

Read the full case study:
www.sperresearch.com/Case-Studies...

#Healthcare #MetabolicDiseases #DiabetesCare #Obesity #GLP1 #SGLT2 #PharmaInsights #MarketResearch

Targeting protein modifications in metabolic diseases
A broad review of protein modifications shaping metabolic disease progression, with implications for diabetes therapy.
doi.org/10.1038/s413...
#MetabolicDiseases #ProteinModifications #DiabetesResearch #TherapeuticTargets

IV Euro Diabetes, Endocrinology & Metabolic Diseases Conference The conference will cover a broad spectrum of topics, including metabolic regulation, obesity and weight management, cardiovascular risk, novel therapeutics,

IV Euro Diabetes, Endocrinology and Metabolic Diseases Conference
September 21-22, 2026
Istanbul, Turkey (Hybrid)

www.vydya.com/events/iv-eu...

#Diabetes #Endocrinology #MetabolicDiseases #Obesity #EndocrineOncology
#DiabetesConference #MedicalConference

🚀 New study highlights DGAT1 as a top target for hyperlipidemia & obesity using a cheminformatics workflow. The team applied 2D descriptors from #alvaDesc.

🔗 doi.org/10.1016/j.ld...
🔗 alvaDesc: alvascience.com/alvadesc

#Cheminformatics #QSAR #DrugDiscovery #MetabolicDiseases #chemsky

Pfizer's $2bn+ obesity bet, and other weight-loss news Pfizer licenses another GLP-1 agonist from YaoPharma, plus clinical updates from Zealand, Structure, Ascletis, Wave, and Boehringer Ingelheim.

#Pfizer #obesity #weightloss #FosunPharma #YaoPharma #GLP1agonist #oralGIPanalogue #Metsera #EliLilly #NovoNordisk #Wegovy #ZealandPharma #metabolicdiseases #Roche #BoehringerIngelheim #GLP1glucagonagonist #StructureTherapeutics #AscletisPharma #WaveLifeSciences #Gubra
zurl.co/AwsrK

This latest review highlights recent advances in understanding #m6Amethylation of RBM15, its molecular regulation in #Cancer and #MetabolicDiseases, and the emerging #therapeutic opportunities in future #GeneTherapy strategies. #medsky

#OpenAccess: www.sciencedirect.com/science/arti...

Experts Call For Urgent Action on Ultra-Processed Foods After Landmark Review Ultra-processed foods are displacing traditional foods and meals globally, degrading diet quality, and contributing to the rise of diet-related chronic diseases.

#mwgic #2025 #Diet #Nutrition #UltraProcessedFoods #MetabolicDiseases #PublicPolicy

www.sciencealert.com/experts-call...

This review examines the effects of #HelicobacterPylori treatment on #Clinical & biochemical outcomes in patients with #NonAlcoholicFattyLiverDisease, offering deeper insight into the role of infection in #MetabolicDiseases. #medsky

Read: link.springer.com/article/10.1...

La Dra. Lucía Martín Banderas, nos manda su reciente publicación en la revista Journal of Biomedical Materials Research. Enhorabuena a todo el equipo.
onlinelibrary.wiley.com/doi/10.1002/...
#cannabisresearch #biotechnology_science #metabolicdiseases #investigacióncannabinoides

Different types of depression linked to different cardiometabolic diseases It is known that depression is linked to an increased incidence of metabolic diseases. Now scientists have discovered that different types of depression are linked to different cardiometabolic disease...

📌 38th ECNP Congress 2025 in the news: Different types of depression linked to different cardiometabolic diseases
➡️ medicalxpress.com/news/2025-10...

#ECNP2025 #depression #MetabolicDiseases

Now open for submissions on the basic, translational and clinical aspects of #endocrinology, both in respect to #obesity as an #endocrinedisease, and its biology, diagnostics, treatment and relationship with other endocrine and #metabolicdiseases
👉 academic.oup.com/obendo

[ALA Client News] Ciloa secures €6.5M government funding from #France2030 ‘Innovation in biotherapies and biomanufacturing’ to develop drug candidate for treatment of obesity and type 2 diabetes

ala.associates/funding/cilo...

#Diabetes #Obesity #MetabolicDiseases
@bpifrance-officiel.bsky.social

The next session is on Genetic Technologies, and the first speaker is Prof. Sabine Fuchs (from @umcutrecht.bsky.social). She will talk about prime editing for inherited metabolic diseases. #NVGCT2025 #metabolicdiseases #primeediting #liver

Fibroblast growth factor 21: An emerging pleiotropic regulator of lipid metabolism and the metabolic network

This review details the mechanisms regulating #FGF21 production, its mechanism of action & biological functions, explores how it regulates #GlucoLipidMetabolism, and lays a theoretical foundation for future research on FGF21-targeted treatment of #MetabolicDiseases. #medsky

buff.ly/kO5JMsJ

Wellcome Connecting Science Meet our keynotes speaking at: Multiomics in Metabolic Disease Conference dates: 4-6 June 2025 Sarah Teichmann Cambridge Stem Cell Institute, UK Matthias Mann Max Planck Institute of Biochemistry, Germany Talk: Mass spectrometry-based proteomics for the diagnosis and classification of metabolic diseases

𝗗𝗼𝗻'𝘁 𝗺𝗶𝘀𝘀 𝗼𝘂𝘁 𝗼𝗻 𝗵𝗶𝗴𝗵-𝗾𝘂𝗮𝗹𝗶𝘁𝘆 𝗶𝗻𝘁𝗲𝗿𝗮𝗰𝘁𝗶𝗼𝗻𝘀 𝘄𝗶𝘁𝗵 𝗹𝗲𝗮𝗱𝗶𝗻𝗴 𝗲𝘅𝗽𝗲𝗿𝘁𝘀 𝗶𝗻 𝗼𝗺𝗶𝗰𝘀 𝘁𝗲𝗰𝗵𝗻𝗼𝗹𝗼𝗴𝗶𝗲𝘀! #MetabolicMultiomics25

Discover the potential of #omics for new clinical treatments for #MetabolicDiseases, at the intersection of research and translational medicine.

Register by 6 May ⏰
📎 bit.ly/3DF6vET

Evidence-Based Nutrition And Behavior Change Science - Dr. Michelle Cardel, PhD, RD, - Chief Nutrition Officer, WeightWatchers, joins me on Progress, Potential, And Possibilities l #ChiefNutritionOfficer #WeightWatchers #Obesity #Diabetes #MetabolicDiseases - www.youtube.com/watch?v=FM42...

Insights into the role of RNA m6A modification in the metabolic process and related diseases

This review summarizes the classic processes of #N6methyladenosine (m6A) modification in different metabolic processes and #metabolicdiseases and discusses the current research status of m6A-targeted therapy in the treatment of metabolic diseases. #medsky

#OpenAccess: buff.ly/BNad2lB

Wellcome Connecting Science Multiomics in Metabolic Disease hybrid conference Conference dates: 4-6 June 2025 Location: Hinxton Hall Conference Centre, Wellcome Genome Campus, UK and online Registration deadlines - In person: 6 May Virtual: 27 May

Join us in person for our #MetabolicMultiomics25 conference!

Explore the application of powerful #omics tools for studying #MetabolicDiseases & cancer.

Discover the potential for new clinical treatments at the intersection of research & translational medicine.

Register by 6 May
📎 bit.ly/3DF6vET

Association between outdoor artificial #light at night and #metabolic diseases in middle-aged to older adults—the CHARLS survey

Our study demonstrated a significant association between higher-intensity outdoor artificial LAN exposure and #metabolicDiseases.
www.frontiersin.org/journals/pub...

#PortfolioNews I NorthSea Therapeutics strengthens leadership & advances metabolic, cholestatic & fibrotic disease therapies.

🔬 Key trials ahead!

👉 https://buff.ly/3Quv4HV

#vc #MetabolicDiseases

My lab at #EmoryUniversity is seeking a #Postdoc candidate with expertise in #proteinbiochemistry to continue our exciting work on engineered protein therapies for #MitochondrialDiseases and #MetabolicDiseases. Email me to discuss this further. Please repost! #Proteinengineering #proteintherapy

🇪🇸 ¡Hola Málaga! ☀️👋🏻 Meet Celina in Torremolinos tomorrow at the #𝗘𝗠𝗕𝗢 𝗪𝗼𝗿𝗸𝘀𝗵𝗼𝗽 on Energy Balance in #MetabolicDiseases!
🔬 Catch her talk on #FemaleResilience #onChip
📅 Wed, Feb 12 | 🕒 3 PM UTC | 🏛 Session #5
💡 For in-person discussions, make sure to swing by her poster #75! #OoC #OrganOnChip #MPS

New Gene Delivery Seminar: Investigating mechanisms of insulin hypersecretion in β-cells

🔴 WATCH LIVE: us06web.zoom.us/webinar/regi...

#Webinar #GeneDelivery #MetabolicDiseases #GeneDeliverySeries #Diabetes #Insulin #Hypersecretion #New #Biotech #Biotechnology #Innovation

Our seminar “Investigating Mechanisms of Insulin Hypersecretion in β-cells” with Dr. Michael Kalway goes live in ONE HOUR! 🚨

Click the link to register for the seminar: us06web.zoom.us/webinar/regi...

#Webinar #GeneDelivery #MetabolicDiseases #GeneDeliverySeries #Diabetes

Our first Gene Delivery Seminar of the year goes live tomorrow: Investigating Mechanisms of Insulin Hypersecretion in β-cells

Click the link to register for the seminar: us06web.zoom.us/webinar/regi...

#Webinar #GeneDelivery #MetabolicDiseases #GeneDeliverySeries #Diabetes

Centre for Medicines Discovery and Boehringer Ingelheim researchers found the enzymatic mechanism for human ceramide synthase, which could help to develop new treatments for #MetabolicDiseases like #diabetes, #NonAlcoholicFattyLiverDisease and #NASH. 🔬

Read more 👉 www.ndm.ox.ac.uk/news/researc...

Survey unveils India's rising tide of metabolic diseases Study reveals high rates of non-communicable metabolic diseases across India, with notable differences in prevalence between urban and rural areas and among different Indian states.

Survey unveils India's rising tide of metabolic diseases 📊🍏💉 www.news-medical.net/news/2024042... #MetabolicDiseases #India #Health #Diabetes #Hypertension #Obesity #Dyslipidemia #PublicHealth #NCDs